Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-002997
Filing Date
2024-04-08
Accepted
2024-04-08 17:23:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 10057
  Complete submission text file 0001950047-24-002997.txt   11555
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40493 | Film No.: 24830518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. KRAUSENSTRASSE 9-10 BERLIN 2M 10117
Business Address
Bardin Stephen (Reporting) CIK: 0001942596 (see all company filings)

Type: 144